Exactech Announces Preliminary 2012 Sales of $224.8 Million and 4th Quarter 2012 Sales of $59.7 Million

[at noodls] – GAINESVILLE, Fla. – January 22, 2013 — Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, announced today … more

View todays social media effects on EXAC

View the latest stocks trending across Twitter. Click to view dashboard

See who Exactech is hiring next, click here to view